Where does ISM stand in terms of research and infrastructure development?
Large pharma industrial houses are happy to have just a few products mostly as over the counter (OTC). Unlike resource being spent on developing new drug molecules, very little money is spent on R&D of ISM drugs. The turnover being small, money that is required to develop new products from traditional medicine is definitely not being pumped in. National medicinal plants board initiatives have started paying results in easing raw material supplies and more efforts in the future for good agricultural practices and clean post harvest practices. This will enable overcome the issue of heavy metals, microbial contamination and pesticide residue issues. Excessive cultivation and storage for a longer time also needs to be curtailed by proper demand assessment. What could be done to enable more Indian products get approval in international markets? A large number of ISM physicians with interdisciplinary qualification are expected to pass out of institutes, even with PhD qualification. These sci
Related Questions
- Can I build and ship a demonstration system to a prospect under the terms of an Internal Research and Development [IR&D] license?
- Are there any encouraging signs of progress in terms of security, economic development, and public sector infrastructure?
- Where do we stand in relation to other local authorities in terms of how far through the development of SDS we are?
